WO2025009590A1 - 組織由来の細胞の培養方法および組織由来の細胞を含む培養装置 - Google Patents
組織由来の細胞の培養方法および組織由来の細胞を含む培養装置 Download PDFInfo
- Publication number
- WO2025009590A1 WO2025009590A1 PCT/JP2024/024233 JP2024024233W WO2025009590A1 WO 2025009590 A1 WO2025009590 A1 WO 2025009590A1 JP 2024024233 W JP2024024233 W JP 2024024233W WO 2025009590 A1 WO2025009590 A1 WO 2025009590A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cells
- derived
- cell
- derived cells
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0657—Cardiomyocytes; Heart cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0679—Cells of the gastro-intestinal tract
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0688—Cells from the lungs or the respiratory tract
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
- C12M35/08—Chemical, biochemical or biological means, e.g. plasma jet, co-culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/02—Coculture with; Conditioned medium produced by embryonic cells
- C12N2502/025—Coculture with; Conditioned medium produced by embryonic cells extra-embryonic cells, e.g. amniotic epithelium, placental cells, Wharton's jelly
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/08—Coculture with; Conditioned medium produced by cells of the nervous system
- C12N2502/081—Coculture with; Conditioned medium produced by cells of the nervous system neurons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N2502/1329—Cardiomyocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/23—Gastro-intestinal tract cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/25—Urinary tract cells, renal cells
- C12N2502/256—Renal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/27—Lung cells, respiratory tract cells
Definitions
- the present invention relates to a method for culturing tissue-derived cells and a culture device containing tissue-derived cells.
- the standard media for culturing tissue-derived cells were DMEM or RPMI-1640 containing 10% to 20% serum (e.g., Scientific Reports volume 12, Article number: 827 (2022)).
- the present invention aims to provide a novel method for co-culturing cells derived from multiple types of tissues and a novel method for culturing target cells using culture supernatants of cells derived from multiple types of tissues.
- One embodiment of the present invention is a cell culture method comprising a step of co-culturing skin-derived cells with one or more types of cells selected from the group consisting of intestine-derived cells, heart-derived cells, brain-derived cells, stomach-derived cells, embryonic membrane-derived cells, kidney-derived cells, and lung-derived cells.
- Another embodiment of the present invention is a cell culture method comprising a step of culturing skin-derived cells in the presence of a culture supernatant obtained by culturing one or more types of cells selected from the group consisting of intestine-derived cells, heart-derived cells, brain-derived cells, stomach-derived cells, embryonic membrane-derived cells, kidney-derived cells, and lung-derived cells.
- the culture supernatant may further contain a culture supernatant obtained by culturing skin-derived cells.
- the culture may also be a co-culture.
- a further embodiment of the present invention is a culture system in which skin-derived cells are co-cultured with one or more cells selected from the group consisting of intestinal-derived cells, cardiac-derived cells, brain-derived cells, stomach-derived cells, embryonic membrane-derived cells, kidney-derived cells, and lung-derived cells.
- a further embodiment of the present invention is a culture system in which skin-derived cells are cultured in the presence of a culture supernatant obtained by culturing one or more cells selected from the group consisting of intestine-derived cells, heart-derived cells, brain-derived cells, stomach-derived cells, embryonic membrane-derived cells, kidney-derived cells, and lung-derived cells.
- the culture supernatant may further comprise a culture supernatant obtained by culturing skin-derived cells.
- the culture may be a co-culture.
- One embodiment of the present invention is a cell culture method comprising a step of co-culturing intestine-derived cells with one or more types of cells selected from the group consisting of skin-derived cells, heart-derived cells, brain-derived cells, stomach-derived cells, embryonic membrane-derived cells, kidney-derived cells, and lung-derived cells.
- Another embodiment of the present invention is a cell culture method comprising a step of culturing intestine-derived cells in the presence of a culture supernatant obtained by culturing one or more types of cells selected from the group consisting of skin-derived cells, heart-derived cells, brain-derived cells, stomach-derived cells, embryonic membrane-derived cells, kidney-derived cells, and lung-derived cells.
- the culture supernatant may further contain a culture supernatant obtained by culturing intestine-derived cells.
- the culture may also be a co-culture.
- a further embodiment of the present invention is a culture system in which intestinal cells are co-cultured with one or more cells selected from the group consisting of skin-derived cells, heart-derived cells, brain-derived cells, stomach-derived cells, embryonic membrane-derived cells, kidney-derived cells, and lung-derived cells.
- a further embodiment of the present invention is a culture system in which intestine-derived cells are cultured in the presence of a culture supernatant obtained by culturing one or more cells selected from the group consisting of skin-derived cells, heart-derived cells, brain-derived cells, stomach-derived cells, embryonic membrane-derived cells, kidney-derived cells, and lung-derived cells.
- the culture supernatant may further comprise a culture supernatant obtained by culturing intestine-derived cells.
- the culture may be a co-culture.
- One embodiment of the present invention is a cell culture method comprising a step of co-culturing heart-derived cells with one or more types of cells selected from the group consisting of skin-derived cells, intestine-derived cells, brain-derived cells, stomach-derived cells, embryonic membrane-derived cells, kidney-derived cells, and lung-derived cells.
- Another embodiment of the present invention is a cell culture method comprising a step of culturing heart-derived cells in the presence of a culture supernatant obtained by culturing one or more types of cells selected from the group consisting of skin-derived cells, intestine-derived cells, brain-derived cells, stomach-derived cells, embryonic membrane-derived cells, kidney-derived cells, and lung-derived cells.
- the culture supernatant may further contain a culture supernatant obtained by culturing heart-derived cells.
- the culture may also be a co-culture.
- a further embodiment of the present invention is a culture system in which cells derived from the heart are co-cultured with one or more cells selected from the group consisting of cells derived from the skin, cells derived from the intestine, cells derived from the brain, cells derived from the stomach, cells derived from embryonic membranes, cells derived from the kidney, and cells derived from the lung.
- a further embodiment of the present invention is a culture system in which heart-derived cells are cultured in the presence of a culture supernatant obtained by culturing one or more cells selected from the group consisting of skin-derived cells, intestine-derived cells, brain-derived cells, stomach-derived cells, embryonic membrane-derived cells, kidney-derived cells, and lung-derived cells.
- the culture supernatant may further comprise a culture supernatant obtained by culturing heart-derived cells.
- the culture may be a co-culture.
- One embodiment of the present invention is a cell culture method comprising a step of co-culturing brain-derived cells with one or more types of cells selected from the group consisting of skin-derived cells, intestine-derived cells, heart-derived cells, stomach-derived cells, embryonic membrane-derived cells, kidney-derived cells, and lung-derived cells.
- Another embodiment of the present invention is a cell culture method comprising a step of culturing brain-derived cells in the presence of a culture supernatant obtained by culturing one or more types of cells selected from the group consisting of skin-derived cells, intestine-derived cells, heart-derived cells, stomach-derived cells, embryonic membrane-derived cells, kidney-derived cells, and lung-derived cells.
- the culture supernatant may further contain a culture supernatant obtained by culturing brain-derived cells.
- the culture may also be a co-culture.
- a further embodiment of the present invention is a culture system in which brain-derived cells are co-cultured with one or more cells selected from the group consisting of skin-derived cells, intestine-derived cells, heart-derived cells, stomach-derived cells, embryonic membrane-derived cells, kidney-derived cells, and lung-derived cells.
- a further embodiment of the present invention is a culture system in which brain-derived cells are cultured in the presence of a culture supernatant obtained by culturing one or more cells selected from the group consisting of skin-derived cells, intestine-derived cells, heart-derived cells, stomach-derived cells, embryonic membrane-derived cells, kidney-derived cells, and lung-derived cells.
- the culture supernatant may further contain a culture supernatant obtained by culturing brain-derived cells.
- the culture may be a co-culture.
- One embodiment of the present invention is a cell culture method comprising a step of co-culturing stomach-derived cells with one or more types of cells selected from the group consisting of skin-derived cells, intestine-derived cells, heart-derived cells, brain-derived cells, embryonic membrane-derived cells, kidney-derived cells, and lung-derived cells.
- Another embodiment of the present invention is a cell culture method comprising a step of culturing stomach-derived cells in the presence of a culture supernatant obtained by culturing one or more types of cells selected from the group consisting of skin-derived cells, intestine-derived cells, heart-derived cells, brain-derived cells, embryonic membrane-derived cells, kidney-derived cells, and lung-derived cells.
- the culture supernatant may further contain a culture supernatant obtained by culturing stomach-derived cells.
- the culture may also be a co-culture.
- a further embodiment of the present invention is a culture system in which stomach-derived cells are co-cultured with one or more cells selected from the group consisting of skin-derived cells, intestine-derived cells, heart-derived cells, brain-derived cells, embryonic membrane-derived cells, kidney-derived cells, and lung-derived cells.
- One embodiment of the present invention is a cell culture method comprising a step of co-culturing embryonic membrane-derived cells with one or more types of cells selected from the group consisting of skin-derived cells, intestine-derived cells, heart-derived cells, brain-derived cells, stomach-derived cells, kidney-derived cells, and lung-derived cells.
- Another embodiment of the present invention is a cell culture method comprising a step of culturing cells derived from an embryonic membrane in the presence of a culture supernatant obtained by culturing one or more types of cells selected from the group consisting of cells derived from the skin, cells derived from the intestine, cells derived from the heart, cells derived from the brain, cells derived from the stomach, cells derived from the kidney, and cells derived from the lung.
- the culture supernatant may further contain a culture supernatant obtained by culturing cells derived from an embryonic membrane.
- the culture may also be a co-culture.
- a further embodiment of the present invention is a culture system in which cells derived from an embryonic membrane are co-cultured with one or more cells selected from the group consisting of cells derived from the skin, cells derived from the intestine, cells derived from the heart, cells derived from the brain, cells derived from the stomach, cells derived from the kidney, and cells derived from the lung.
- a further embodiment of the present invention is a culture system in which cells derived from an embryonic membrane are cultured in the presence of a culture supernatant obtained by culturing one or more cells selected from the group consisting of cells derived from the skin, cells derived from the intestine, cells derived from the heart, cells derived from the brain, cells derived from the stomach, cells derived from the kidney, and cells derived from the lung.
- the culture supernatant may further comprise a culture supernatant obtained by culturing cells derived from an embryonic membrane.
- the culture may be a co-culture.
- One embodiment of the present invention is a cell culture method comprising a step of co-culturing kidney-derived cells and one or more types of cells selected from the group consisting of skin-derived cells, intestine-derived cells, heart-derived cells, brain-derived cells, stomach-derived cells, embryonic membrane-derived cells, and lung-derived cells.
- Another embodiment of the present invention is a cell culture method comprising a step of culturing kidney-derived cells in the presence of a culture supernatant obtained by culturing one or more types of cells selected from the group consisting of skin-derived cells, intestine-derived cells, heart-derived cells, brain-derived cells, stomach-derived cells, embryonic membrane-derived cells, and lung-derived cells.
- the culture supernatant may further contain a culture supernatant obtained by culturing kidney-derived cells.
- the culture may also be a co-culture.
- One embodiment of the present invention is a cell culture method comprising a step of co-culturing lung-derived cells with one or more types of cells selected from the group consisting of skin-derived cells, intestine-derived cells, heart-derived cells, brain-derived cells, stomach-derived cells, embryonic membrane-derived cells, and kidney-derived cells.
- Another embodiment of the present invention is a cell culture method comprising a step of culturing lung-derived cells in the presence of a culture supernatant obtained by culturing one or more types of cells selected from the group consisting of skin-derived cells, intestine-derived cells, heart-derived cells, brain-derived cells, stomach-derived cells, embryonic membrane-derived cells, and kidney-derived cells.
- the culture supernatant may further contain a culture supernatant obtained by culturing lung-derived cells.
- the culture may also be a co-culture.
- a further embodiment of the present invention is a culture system in which lung-derived cells are co-cultured with one or more cells selected from the group consisting of skin-derived cells, intestine-derived cells, heart-derived cells, brain-derived cells, stomach-derived cells, embryonic membrane-derived cells, and kidney-derived cells.
- a further embodiment of the present invention is a culture system in which lung-derived cells are cultured in the presence of a culture supernatant obtained by culturing one or more types of cells selected from the group consisting of skin-derived cells, intestine-derived cells, heart-derived cells, brain-derived cells, stomach-derived cells, embryonic membrane-derived cells, and kidney-derived cells.
- the culture supernatant may further contain a culture supernatant obtained by culturing lung-derived cells.
- the culture may be a co-culture.
- the method for culturing skin-derived cells is a culture method comprising a step of co-culturing skin-derived cells with one or more types of cells selected from the group consisting of intestine-derived cells, heart-derived cells, brain-derived cells, stomach-derived cells, fetal membrane-derived cells, kidney-derived cells, and lung-derived cells.
- the culture for obtaining the culture supernatant may be a co-culture.
- Method for culturing intestinal-derived cells is a culture method comprising a step of co-culturing intestine-derived cells with one or more types of cells selected from the group consisting of skin-derived cells, heart-derived cells, brain-derived cells, stomach-derived cells, embryonic membrane-derived cells, kidney-derived cells, and lung-derived cells.
- the culture supernatant may further contain a culture supernatant obtained by culturing cells derived from the intestine.
- the culture for obtaining the culture supernatant may be a co-culture.
- Another embodiment of the present invention is a cell culture method comprising the step of culturing heart-derived cells in the presence of a culture supernatant obtained by culturing one or more types of cells selected from the group consisting of skin-derived cells, intestine-derived cells, brain-derived cells, stomach-derived cells, embryonic membrane-derived cells, kidney-derived cells, and lung-derived cells.
- the method for culturing brain-derived cells is a culture method comprising a step of co-culturing brain-derived cells with one or more types of cells selected from the group consisting of skin-derived cells, intestine-derived cells, heart-derived cells, stomach-derived cells, embryonic membrane-derived cells, kidney-derived cells, and lung-derived cells.
- Another embodiment of the present invention is a cell culture method comprising the step of culturing brain-derived cells in the presence of a culture supernatant obtained by culturing one or more types of cells selected from the group consisting of skin-derived cells, intestine-derived cells, heart-derived cells, stomach-derived cells, embryonic membrane-derived cells, kidney-derived cells, and lung-derived cells.
- the culture for obtaining the culture supernatant may be a co-culture.
- Method for culturing stomach-derived cells is a culture method comprising a step of co-culturing stomach-derived cells with one or more types of cells selected from the group consisting of skin-derived cells, intestine-derived cells, heart-derived cells, brain-derived cells, embryonic membrane-derived cells, kidney-derived cells, and lung-derived cells.
- Another embodiment of the present invention is a cell culture method comprising the step of culturing stomach-derived cells in the presence of a culture supernatant obtained by culturing one or more types of cells selected from the group consisting of skin-derived cells, intestine-derived cells, heart-derived cells, brain-derived cells, embryonic membrane-derived cells, kidney-derived cells, and lung-derived cells.
- the culture for obtaining the culture supernatant may be a co-culture.
- Method for culturing cells derived from embryonic membrane is a culture method comprising a step of co-culturing embryonic membrane-derived cells and one or more types of cells selected from the group consisting of skin-derived cells, intestine-derived cells, heart-derived cells, brain-derived cells, stomach-derived cells, kidney-derived cells, and lung-derived cells.
- Another embodiment of the present invention is a cell culture method comprising the step of culturing embryonic membrane-derived cells in the presence of a culture supernatant obtained by culturing one or more types of cells selected from the group consisting of skin-derived cells, intestine-derived cells, heart-derived cells, brain-derived cells, stomach-derived cells, kidney-derived cells, and lung-derived cells.
- the culture for obtaining the culture supernatant may be a co-culture.
- Method for culturing kidney-derived cells is a culture method comprising a step of co-culturing kidney-derived cells with one or more types of cells selected from the group consisting of skin-derived cells, intestine-derived cells, heart-derived cells, brain-derived cells, stomach-derived cells, embryonic membrane-derived cells, and lung-derived cells.
- Another embodiment of the present invention is a cell culture method comprising the step of culturing kidney-derived cells in the presence of a culture supernatant obtained by culturing one or more types of cells selected from the group consisting of skin-derived cells, intestine-derived cells, heart-derived cells, brain-derived cells, stomach-derived cells, embryonic membrane-derived cells, and lung-derived cells.
- Another embodiment of the present invention is a cell culture method comprising the step of culturing lung-derived cells in the presence of a culture supernatant obtained by culturing one or more types of cells selected from the group consisting of skin-derived cells, intestine-derived cells, heart-derived cells, brain-derived cells, stomach-derived cells, embryonic membrane-derived cells, and kidney-derived cells.
- the culture for obtaining the culture supernatant may be a co-culture.
- Culture system refers to a system in a culture state including a culture device including a cell culture vessel, a cell culture medium, and cultured cells.
- the culture device may be provided with a medium supply container for supplying fresh cell culture medium, a medium recovery container for recovering cultured cell culture medium, and the like.
- the cell culture vessel is not particularly limited, and may be, for example, a culture tank, a glass petri dish, or a plastic dish. Those skilled in the art can select a cell culture medium suitable for the cells to be cultured.
- the medium may be a serum-containing medium, but is preferably a serum-free medium in terms of ease of controlling the substances contained therein.
- multiple types of cells may be cultured in one culture vessel, or an independent culture vessel may be provided for each type of cell, and the cells may be grown separately by culturing them while sharing the same culture medium.
- the culture vessels may be connected to each other so that the culture medium is in communication between the culture vessels.
- the method of connecting the culture vessels can be determined appropriately according to the purpose.
- the culture vessels may be connected to each other with tubes, and an opening and closing control device such as an opening and closing valve may be provided in the tubes between the culture vessels, and the communication of the culture medium may be controlled by controlling the opening and closing.
- a pump may also be provided in the tubes between the culture vessels to flow the culture medium in either direction.
- the culture vessels when there are two culture vessels, they may be connected with one tube, or they may be connected with two or more tubes. By connecting the culture vessels with multiple tubes, the medium can be circulated. When there are three or more culture vessels, they may be connected in series or in parallel, and an appropriate culture system can be formed by connecting the culture vessels appropriately according to the purpose.
- culture vessels There may be one or more culture vessels for each cell. In either case, appropriate culture vessels can be combined to form an appropriate culture system according to the purpose.
- the animals from which the skin, intestine, heart, brain, stomach, kidney, and lung tissues are obtained are not particularly limited, but are preferably vertebrates such as mammals, birds, reptiles, and amphibians.
- the species from which the skin-derived cells, intestine-derived cells, heart-derived cells, brain-derived cells, stomach-derived cells, kidney-derived cells, and lung-derived cells are derived are not particularly limited, but are preferably vertebrates, and may be any of mammals, reptiles, birds, and amphibians, for example, humans, cows, pigs, rabbits, and chickens.
- the animals from which the embryonic membrane is obtained are not particularly limited, but are preferably birds or reptiles, as long as they are oviparous.
- the species from which the embryonic membrane-derived cells are derived are not particularly limited, but may be birds or reptiles, or may be chickens. In the case of chickens, they may be 0-day to 21-day embryos, but may also be 2-day to 19-day embryos, 4-day to 17-day embryos, or 6-day to 15-day embryos.
- the cells of each tissue may be derived from the same animal or from different animals.
- Skin-derived cells, intestine-derived cells, heart-derived cells, brain-derived cells, stomach-derived cells, embryonic membrane-derived cells, kidney-derived cells, and lung-derived cells can be obtained by extracting and using the skin, intestine, heart, brain, stomach, embryonic membrane, kidney, and lung from an animal embryo, respectively, or by using the whole embryo and isolating the cells by chemical treatment with enzymes such as collagenase, dispase, and trypsin, or by physical treatment such as cutting and crushing with a scalpel or razor, or pipetting using a microchip. Specific methods are not particularly limited as long as they are already established as technical common knowledge and can recover cells alive.
- Cells derived from the skin include epithelial cells and dermal cells.
- Cells derived from the intestine include one or more cells selected from the group consisting of intestinal epithelial cells, CBC cells, Paneth cells, enteroendocrine cells, goblet cells, absorptive epithelial cells, M cells, intestinal wall cells, connective tissue cells, muscle cells, fibroblasts, vascular endothelial cells, vascular epithelial cells, and their precursor cells or stem cells.
- the intestine may be the duodenum, small intestine, large intestine, or colon, or may be a mixture of two or more of these.
- Cells derived from the heart include one or more cells selected from the group consisting of cardiomyocytes, nerve cells, connective tissue cells, fibroblasts, vascular endothelial cells, vascular epithelial cells, blood cells, and their precursor cells or stem cells.
- the brain-derived cells include one or more cells selected from the group consisting of neural cells, glial cells, pituitary cells, vascular endothelial cells, vascular epithelial cells, and their precursor cells or stem cells.
- the cells derived from the stomach include one or more cells selected from the group consisting of chief cells, parietal cells, accessory cells, and their progenitor cells or stem cells.
- Cells derived from embryonic membranes include one or more cells selected from the group consisting of amnion, chorion, allantois, and yolk sac.
- Cells derived from the kidney include one or more cells selected from the group consisting of epithelial cells, endothelial cells, mesangial cells, visceral epithelial cells, parietal visceral cells, endothelial cells that make up the renal tubules, epithelial cells, connective tissue cells that fill other tissues, fibroblasts, vascular endothelial cells, vascular epithelial cells, and their precursor cells or stem cells.
- the lung-derived cells include one or more cells selected from the group consisting of endothelial cells, alveolar epithelial cells, and their progenitor cells or stem cells.
- the cells may be primary cultured cells or established cultured cell lines. They may also be cultured in the form of tissues or organs, in the form of cell clumps, or as individually isolated cells.
- the culture may be either suspension culture or adhesion culture. It may also be flat culture or three-dimensional culture. Those skilled in the art can easily and appropriately determine which culture to select depending on the cell type.
- the culture supernatant can be collected after, for example, seeding cells in a cell container at a density of 1 ⁇ 10 4 cells/1 ⁇ 10 7 cells/mL and culturing for about 1 to 30 days. After that, the cells may be centrifuged to remove precipitates such as cell debris.
- the obtained culture supernatant may be used as is (i.e., 100% cell supernatant) to culture the cells to be grown, or a medium to which 10% or more, 30% or more, 50% or more, or 70% or more of fresh medium has been added may be used.
- the two or more types of cells to obtain the culture supernatant may be cultured separately and the supernatants may be mixed, or some or all of the cells may be co-cultured.
- some or all of the cells to be co-cultured may be cultured in one culture container, or an independent culture container may be provided for each cell, and the cells may be grown separately by culturing them while sharing a medium.
- the culture vessels may be connected to each other so that the medium communicates between the culture vessels.
- the manner in which the culture vessels are connected to each other can be appropriately determined according to the purpose. For example, some or all of the culture vessels may be connected in a ring shape, and a culture vessel for the same type of cells as the cells to be grown may be included in the ring shape.
- the obtained cell count was calculated as a relative value when the number of cells obtained by culturing a single type of cell under the same conditions separately from the plates # 1 to # 3 was set to 1. Each experiment was repeated 8 times, and the average value ⁇ standard error is shown in Table 1.
- Evaluation For each combination if the value obtained for a particular cell is greater than 1 (#1>1), it is considered that the cell proliferation of that particular cell has been promoted. Such cells were marked with a circle (evaluation 1). Next, if all values obtained for the three cells used in the combination are greater than 1 (All>1), it is considered that the cell proliferation of the three cells used in the combination has been promoted. Such cells were marked with a circle (evaluation 2). These evaluations are described in each table below. [4] Results
- the proliferation of skin-derived cells can be promoted by co-culturing them with various cell types.
- a cell selected from the group consisting of an intestinal cell, a heart cell, a brain cell, a stomach cell, a kidney cell, and a lung cell (2) A cell selected from the group consisting of a heart-derived cell, a brain-derived cell, a stomach-derived cell, an embryonic membrane-derived cell, and a lung-derived cell; (3) A cell selected from the group consisting of a brain-derived cell, a stomach-derived cell, an embryonic membrane-derived cell, and a lung-derived cell; (4) A cell selected from the group consisting of a stomach-derived cell, a kidney-derived cell, an embryonic membrane-derived cell, and a lung-derived cell; (5) A cell selected from the group consisting of a kidney-derived cell, an embryonic membrane-derived cell, and a lung-derived cell; (6) Embryonic membrane-derived cells and lung-derived cells;
- the proliferation of cardiac cells can be promoted by co-culturing them with various cell types.
- a combination of cells selected from the group consisting of:
- the proliferation of brain-derived cells can be promoted by co-culturing them with various cell types.
- heart-derived cells and kidney-derived cells (4) Cells derived from the stomach and cells derived from the lungs, (5) Kidney-derived cells and lung-derived cells, (6) Embryonic membrane-derived cells and lung-derived cells, When co-cultured with a combination of cells selected from the group consisting of, the proliferation of brain-derived cells was significantly promoted.
- stomach-derived cells can be promoted by co-culturing them with various cell types.
- Brain-derived cells and embryonic membrane-derived cells (4) Kidney-derived cells and embryonic membrane-derived cells, (5) Embryonic membrane-derived cells and lung-derived cells, When co-cultured with a combination of cells selected from the group consisting of:
- kidney-derived cells can be promoted by co-culturing them with various cell types.
- heart-derived cells and lung-derived cells (4) stomach-derived cells and embryonic membrane-derived cells;
- lung-derived cells can be promoted by co-culturing them with various cell types.
- heart-derived cells and stomach-derived cells (4)
- stomach-derived cells and kidney-derived cells (6) Kidney-derived cells and embryonic membrane-derived cells,
- the proliferation of embryonic membrane-derived cells can be promoted by co-culturing them with various cell types.
- the present invention provides a method for culturing tissue-derived cells and a culture device containing tissue-derived cells.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Developmental Biology & Embryology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Pregnancy & Childbirth (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202480041974.6A CN121548633A (zh) | 2023-07-06 | 2024-07-04 | 来自组织的细胞的培养方法和包含来自组织的细胞的培养装置 |
| JP2025531593A JPWO2025009590A1 (cg-RX-API-DMAC7.html) | 2023-07-06 | 2024-07-04 | |
| EP24836102.4A EP4741493A1 (en) | 2023-07-06 | 2024-07-04 | Method for culturing tissue-derived cells, and culture device containing tissue-derived cells |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023-111706 | 2023-07-06 | ||
| JP2023111706 | 2023-07-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2025009590A1 true WO2025009590A1 (ja) | 2025-01-09 |
Family
ID=94171922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2024/024233 Ceased WO2025009590A1 (ja) | 2023-07-06 | 2024-07-04 | 組織由来の細胞の培養方法および組織由来の細胞を含む培養装置 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4741493A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JPWO2025009590A1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN121548633A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2025009590A1 (cg-RX-API-DMAC7.html) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010511375A (ja) * | 2005-12-01 | 2010-04-15 | エイジェンシー フォー サイエンス,テクノロジー アンド リサーチ | 組織工学の足場としての三次元再構成細胞外マトリクス |
| WO2017183675A1 (ja) * | 2016-04-19 | 2017-10-26 | 凸版印刷株式会社 | 薬剤耐性を有する細胞を作製する方法、抗ガン剤をスクリーニングするための方法、及び抗ガン剤スクリーニング用キット |
| WO2020096004A1 (ja) * | 2018-11-08 | 2020-05-14 | インテグリカルチャー株式会社 | 動物細胞増殖促進剤、動物細胞培養用培地及び動物細胞培養装置 |
| WO2021075528A1 (ja) * | 2019-10-17 | 2021-04-22 | 公立大学法人横浜市立大学 | 薬物毒性評価方法 |
| JP2023111706A (ja) | 2022-01-31 | 2023-08-10 | 株式会社吉野工業所 | 繰出容器 |
-
2024
- 2024-07-04 JP JP2025531593A patent/JPWO2025009590A1/ja active Pending
- 2024-07-04 CN CN202480041974.6A patent/CN121548633A/zh active Pending
- 2024-07-04 WO PCT/JP2024/024233 patent/WO2025009590A1/ja not_active Ceased
- 2024-07-04 EP EP24836102.4A patent/EP4741493A1/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010511375A (ja) * | 2005-12-01 | 2010-04-15 | エイジェンシー フォー サイエンス,テクノロジー アンド リサーチ | 組織工学の足場としての三次元再構成細胞外マトリクス |
| WO2017183675A1 (ja) * | 2016-04-19 | 2017-10-26 | 凸版印刷株式会社 | 薬剤耐性を有する細胞を作製する方法、抗ガン剤をスクリーニングするための方法、及び抗ガン剤スクリーニング用キット |
| WO2020096004A1 (ja) * | 2018-11-08 | 2020-05-14 | インテグリカルチャー株式会社 | 動物細胞増殖促進剤、動物細胞培養用培地及び動物細胞培養装置 |
| WO2021075528A1 (ja) * | 2019-10-17 | 2021-04-22 | 公立大学法人横浜市立大学 | 薬物毒性評価方法 |
| JP2023111706A (ja) | 2022-01-31 | 2023-08-10 | 株式会社吉野工業所 | 繰出容器 |
Non-Patent Citations (3)
| Title |
|---|
| ANONYMOUS: "How To Grow Cultured Meat Without Immortalized Cell Lines And Growth Factors", 12 May 2020 (2020-05-12), XP093258767, Retrieved from the Internet <URL:https://new-harvest.org/grow-cultured-meat-without-immortalized-cell-lines-growth-factors/> * |
| ANONYMOUS: "The world's first cultured meat production method using organ-organ interactions has been established - a method for culturing chicken and duck liver-derived cells in serum-free basal medium -", INTEGRICULTURE.COM - NEWS, XP009561176, Retrieved from the Internet <URL:https://integriculture.com/news/research/273/> [retrieved on 20240904] * |
| SCIENTIFIC REPORTS, vol. 12, 2022 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2025009590A1 (cg-RX-API-DMAC7.html) | 2025-01-09 |
| CN121548633A (zh) | 2026-02-17 |
| EP4741493A1 (en) | 2026-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7628338B2 (ja) | 動物細胞増殖促進剤、動物細胞培養用培地及び動物細胞培養装置 | |
| CA2552288C (en) | Novel culture systems for ex vivo development | |
| WO2023132371A1 (ja) | 肝臓由来の細胞の培養方法および肝臓由来の細胞を含む培養系 | |
| JP2002536012A (ja) | 鳥類の多能性胚性生殖細胞株 | |
| CN114752565B (zh) | 带有免疫细胞的视网膜类器官及其构建方法 | |
| CN115747140A (zh) | 一种诱导鸡胚胎干细胞分化生成原始生殖细胞的方法 | |
| CN117004555A (zh) | 一种细胞培养肉的制备方法 | |
| CN118291366A (zh) | 一种适用于PGCs体外分离培养的改良培养基及培养方法 | |
| CN114874971B (zh) | 一种细胞培养液及其在鸡小肠类器官培养中的应用 | |
| KR20040091346A (ko) | 조류 원시생식세포의 생식선 전이 효율의 개선방법 | |
| CN120574889A (zh) | 一种基于荧光标记的鸡性别鉴定方法 | |
| JP4267689B2 (ja) | 鳥類由来の細胞の培養方法および該培養方法によって得られた細胞系 | |
| CN101423819A (zh) | 一种培养鸡胚胎干细胞的方法及其专用培养液 | |
| WO2024147330A1 (ja) | 筋肉由来の細胞の培養方法および筋肉由来の細胞を含む培養装置 | |
| JPWO1996006160A1 (ja) | 鳥類由来の細胞の培養方法および該培養方法によって得られた細胞系 | |
| CN121548633A (zh) | 来自组织的细胞的培养方法和包含来自组织的细胞的培养装置 | |
| CN118581031B (zh) | 一种鹅肾脏类器官及其培养方法、应用 | |
| RU2794773C1 (ru) | Способ культивирования биомассы миобластов, полученных из мышц стерляди | |
| HK40046610A (en) | Animal cell growth promoter, culture medium for animal cell culture, and animal cell culture apparatus | |
| CN121825864A (zh) | 一种驼背鲈鳃盖骨组织成骨细胞系的建立及应用 | |
| JPH07322790A (ja) | 鳥類始原生殖細胞の増殖培養法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 24836102 Country of ref document: EP Kind code of ref document: A1 |
|
| ENP | Entry into the national phase |
Ref document number: 2025531593 Country of ref document: JP Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2025531593 Country of ref document: JP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2024836102 Country of ref document: EP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| ENP | Entry into the national phase |
Ref document number: 2024836102 Country of ref document: EP Effective date: 20260206 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 11202600100W Country of ref document: SG |
|
| WWP | Wipo information: published in national office |
Ref document number: 11202600100W Country of ref document: SG |
|
| WWP | Wipo information: published in national office |
Ref document number: 2024836102 Country of ref document: EP |